Phase IIIB Switching From Intravenous to Subcutaneous Study
Public ClinicalTrials.gov record NCT00663702. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3B Multi-center Open-Label Study to Evaluate the Safety of Abatacept in Subjects Who Switch From Intravenous to Subcutaneous Abatacept Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether switching to subcutaneous administration of abatacept will be safe in participants with rheumatoid arthritis who previously received long-term therapy with intravenous abatacept
Study identification
- NCT ID
- NCT00663702
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 123 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2008
- Primary completion
- Nov 30, 2009
- Completion
- Dec 31, 2011
- Last update posted
- Mar 8, 2015
2008 – 2012
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rheumatology Associates Of N. Al, P.C. | Huntsville | Alabama | 35801 | — |
| Allergy & Rheumatology Medical Clinic, Inc. | La Jolla | California | 92037 | — |
| Valerius Medical Group &Research Ctr. Of Greater Long Beach | Long Beach | California | 90806 | — |
| Desert Medical Advances | Palm Desert | California | 92260 | — |
| Inland Rheumatology Clinical Trials Inc. | Upland | California | 91786 | — |
| Arthritis & Rheumatic Disease Specialties | Aventura | Florida | 33180 | — |
| Diagnostic Rheumatology And Research,Pc | Indianapolis | Indiana | 46227 | — |
| Graves Gilbert Clinic | Bowling Green | Kentucky | 42101 | — |
| Physician Research Collaboration, Llc | Lincoln | Nebraska | 68516 | — |
| Innovative Health Research | Las Vegas | Nevada | 89128 | — |
| The Center For Rheumatology, Llp | Albany | New York | 12206 | — |
| The Arthritis Clinic & Carolina Bone & Joint | Charlotte | North Carolina | 28210 | — |
| Unifour Medical Research | Hickory | North Carolina | 28601 | — |
| Cincinnati Rheumatic Disease Study Group | Cincinnati | Ohio | 45219 | — |
| Portland Rheumatology Clinic | Lake Oswego | Oregon | 97035 | — |
| Rheumatic Disease Associates, Ltd. | Willow Grove | Pennsylvania | 19090 | — |
| Walter F. Chase, Md | Austin | Texas | 78705 | — |
| Arthritis Centers Of Texas | Dallas | Texas | 75246 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00663702, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 8, 2015 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00663702 live on ClinicalTrials.gov.